Jason Zemansky
Stock Analyst at B of A Securities
(4.56)
# 292
Out of 4,667 analysts
32
Total ratings
60.87%
Success rate
25.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $84 → $86 | $72.67 | +18.34% | 8 | Oct 9, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $15.95 | +94.36% | 3 | Aug 15, 2024 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $24 → $23 | $14.62 | +57.32% | 4 | Aug 9, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $2.41 | +3.73% | 5 | Jun 20, 2024 | |
| CYTK Cytokinetics | Maintains: Neutral | $70 → $60 | $49.86 | +20.34% | 3 | May 23, 2024 | |
| ALVR AlloVir | Downgrades: Underperform | $17 → $1 | $0.57 | +75.41% | 2 | Dec 26, 2023 | |
| KURA Kura Oncology | Initiates: Buy | $31 | $15.91 | +94.85% | 1 | Aug 11, 2023 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.64 | +509.76% | 4 | May 12, 2023 | |
| ALLK Allakos | Maintains: Buy | $145 → $155 | $0.94 | +16,403.41% | 2 | Dec 13, 2021 |
Insmed
Oct 9, 2024
Maintains: Buy
Price Target: $84 → $86
Current: $72.67
Upside: +18.34%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $15.95
Upside: +94.36%
Arcus Biosciences
Aug 9, 2024
Maintains: Neutral
Price Target: $24 → $23
Current: $14.62
Upside: +57.32%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $2.41
Upside: +3.73%
Cytokinetics
May 23, 2024
Maintains: Neutral
Price Target: $70 → $60
Current: $49.86
Upside: +20.34%
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17 → $1
Current: $0.57
Upside: +75.41%
Kura Oncology
Aug 11, 2023
Initiates: Buy
Price Target: $31
Current: $15.91
Upside: +94.85%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.64
Upside: +509.76%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: $145 → $155
Current: $0.94
Upside: +16,403.41%